The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Analytics · Impurities & related substances

Where impurities in solid-phase peptide synthesis come from

Solved 1 hidden by flag
Solved by k.asante in post #7
Where the impurities in solid-phase peptide synthesis reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.

Jump to the accepted answer →

LC
l.chevalierTL3Regular29 Jul 2025#1

Where impurities in solid-phase peptide synthesis come from Writing it up because I had to work it out twice and would rather nobody else did.

Impurities in solid-phase peptide synthesis, and specifically the version of it that the documentation does not cover. The maintained page handles the general case well and stops exactly where my question starts.

Setting out the gap in case it is a gap in the page rather than a gap in what is known.

4 likes 12mo
DS
dr_seongTL3Physician9 Aug 2025#2

An update on my earlier impurities in solid-phase peptide synthesis post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.

0 likes 12mo
PO
p.ostergaardTL216 Aug 2025#3
l.chevalier, post #1: Where impurities in solid-phase peptide synthesis come from Writing it up because I had to work it out twice and would rather nobody else did. Impurities in solid-phase peptide synthesis, and specifically the version of it that the documentation does not cover. The maintained page handles the general case well and stops exactly where my… Go to post

Comparing impurity profiles across suppliers is much more informative than comparing purity figures, and almost nobody has the documents to do it.

I would want to see it done twice before believing it once.

20 likes in reply to #1 11mo
CL
customs_ledgerTL3Regular24 Aug 2025 · edited#4
l.chevalier, post #1: Where impurities in solid-phase peptide synthesis come from Writing it up because I had to work it out twice and would rather nobody else did. Impurities in solid-phase peptide synthesis, and specifically the version of it that the documentation does not cover. The maintained page handles the general case well and stops exactly where my… Go to post

The opening post answers the question as asked. The question underneath it is different.

Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off the column does not appear in the area percentage.

Reading it back, the second half matters more than the first.

8 likes in reply to #1 11mo
NK
n.kravchenkoTL230 Aug 2025#5

Worth separating two things that the opening post runs together.

Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the residue's hydrophobicity. They are the most common impurity in solid-phase synthesis.

I would hold that lightly until someone with a larger sample weighs in.

0 likes 11mo
WN
w.novakTL3Regular5 Sep 2025#6

That is a fair summary of where the discussion has got to.

0 likes 11mo
KA
k.asanteTL2 Solution11 Sep 2025#7
p.ostergaard, post #3: Comparing impurity profiles across suppliers is much more informative than comparing purity figures, and almost nobody has the documents to do it. I would want to see it done twice before believing it once. Go to post

Where the impurities in solid-phase peptide synthesis reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.

14 likes in reply to #3 11mo
CO
c.okaforTL3Regular17 Sep 2025#8

A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful.

Two sources, same conclusion, and I could not rule out that one copied the other.

5 likes 10mo
FS
f.sjobergTL222 Sep 2025 · edited#9

The honest reading of a purity figure: it is an upper bound on how much of what the method could see was the intended species, under one integration convention, on one sample.

I would not lead a decision with this, but I would not ignore it either.

0 likes 10mo
DF
d.fontaineTL228 Sep 2025#10
O
OstrowskiTL2Member3 Oct 2025#11

Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete certificate.

Adding the caveat now so it does not have to be extracted later.

0 likes 10mo
JS
j.silvaTL28 Oct 2025#12
T
ThibodeauTL3Regular13 Oct 2025#13
k.asante, post #7: Where the impurities in solid-phase peptide synthesis reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for. Go to post

Confirming post #11 from a second method, which matters more than confirming it from a second person.

Relative response factors mean impurities are not detected in proportion to how much of them is present. A one per cent peak is not one per cent by mass unless the response factors happen to match.

9 likes in reply to #7 9mo
MR
m.restrepoTL218 Oct 2025#14

On impurities in solid-phase peptide synthesis I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get heated.

21 likes 9mo
LO
l.oseiTL223 Oct 2025 · edited#15

Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area percent. How related they can be before they exceed specification is a regulatory question.

I am aware this is the third time this month I have made this point.

29 likes 9mo
AA
a.asanteTL228 Oct 2025#16

Worth separating two things that post #13 runs together.

Peptide impurities that differ by a single residue are the hardest to resolve and the most likely to be biologically relevant, which is an unfortunate combination.

0 likes 9mo
DB
d.bakkerTL21 Nov 2025#17
d.fontaine, post #10: Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups. Adding it in case it saves somebody the afternoon it cost me. Go to post

The honest answer on impurities in solid-phase peptide synthesis is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter.

Most people get the first two right and then argue about the fourth.

5 likes in reply to #10 9mo
PM
p.marchettiTL26 Nov 2025#18

The related-substances total is only as informative as the method that generated it. Two per cent by a method that resolves everything is a different statement from two per cent by a method that resolves little.

Reporting the observation and leaving the explanation open deliberately.

15 likes 9mo
I
IMainwaringTL3Regular11 Nov 2025#19

The arithmetic in post #18 is right; the assumption feeding it is the part to check.

Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species appear. Reducing conditions (like DTT) convert them back.

22 likes 9mo
BA
b.adeyemiTL215 Nov 2025#20

Answering the question post #16 raises rather than the one it answers.

Adding a reference point for impurities in solid-phase peptide synthesis. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.

0 likes 8mo
ZI
z.iyerTL220 Nov 2025#21
n.kravchenko, post #5: Worth separating two things that the opening post runs together. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the residue's hydrophobicity. They are the most common impurity in solid-phase synthesis. I would hold that lightly… Go to post

Practical answer on impurities in solid-phase peptide synthesis, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated explanation is needed. It usually is not.

33 likes in reply to #5 8mo
MS
m.stephanopoulosTL3Regular24 Nov 2025#22

Oxidation at methionine or tryptophan adds sixteen per oxygen and typically elutes earlier. In aged material it is the modification that grows.

17 likes 8mo
CS
c.silvaTL228 Nov 2025#23

Everything in post #21 holds. The case it does not cover is the one I have.

Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and have different hydrophobicity. They are usually well separated.

Somebody will have a better source than mine, and I hope they post it.

7 likes 8mo
RG
r.girardTL23 Dec 2025#24
d.fontaine, post #10: Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups. Adding it in case it saves somebody the afternoon it cost me. Go to post

Fine by me. I had wanted a stronger conclusion and there is not one available.

1 like in reply to #10 8mo
DT
d.tammTL27 Dec 2025#25

Impurities in solid-phase peptide synthesis is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.

25 likes 8mo
AZ
a.zamoraTL211 Dec 2025#26

Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the monomer on HPLC depending on the method.

11 likes 8mo
AA
a.adebayoTL215 Dec 2025#27

Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural isomer with the same mass but a different sequence. No chromatographic purity method detects this without a reference standard.

3 likes 7mo
BF
b.fonsecaTL220 Dec 2025#28
f.sjoberg, post #9: The honest reading of a purity figure: it is an upper bound on how much of what the method could see was the intended species, under one integration convention, on one sample. I would not lead a decision with this, but I would not ignore it either. Go to post

Post #25 answers the question as asked. The question underneath it is different.

I would call the community position on impurities in solid-phase peptide synthesis likely rather than established, and I would be comfortable defending that hedge.

0 likes in reply to #9 7mo
MP
mira.patelTL4 Admin24 Dec 2025#29
b.fonseca, post #28: Post #25 answers the question as asked. The question underneath it is different. I would call the community position on impurities in solid-phase peptide synthesis likely rather than established, and I would be comfortable defending that hedge. Go to post

I had written a reply contradicting post #25 and deleted it. Here is what survived.

Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has characterised its own process. That is a meaningful difference in documentation quality.

It reads as pedantry until the day it does not.

0 likes in reply to #28 7mo
AN
a.novakTL228 Dec 2025#30
c.silva, post #23: Everything in post #21 holds. The case it does not cover is the one I have. Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and have different hydrophobicity. They are usually well separated. Somebody will have a better… Go to post

Confirming post #29 from a second method, which matters more than confirming it from a second person.

Deletion sequences arise from incomplete coupling and are lower by one residue mass. Where they elute depends on the hydrophobicity of the residue that is missing, so they can appear on either side of the main peak.

Posting it because the silence on this was starting to look like agreement.

32 likes in reply to #23 7mo